|
Age, y
|
42.3 (14.5)*
|
39.7 (11.9)*
|
0.57
| |
|
Sex ratio (M,%)
|
62.5
|
63.2
|
0.96
| |
|
Origin
| | |
0.96
| |
|
European (%)
|
75.0
|
73.7
|
|
African (%)
|
25.0
|
26.3
|
|
Current smokers (%)
|
0
|
31.6
|
0.03
| |
|
Duration of diagnosed infection, years
|
2.2 (2.9)*
|
1.6 (1.8)*
|
0.46
| |
|
CDC categories
| | |
0.31
| |
|
A + B (%)
|
81.3
|
94.7
|
|
C (%)
|
18.7
|
5.3
|
|
Viral load (log10/ml)
|
5.05 (0.85)*
|
5.04 (0.55)*
|
0.97
| |
|
CD4 lymphocytes/ml
|
240 (153)*
|
240 (131)*
|
0.90
| |
|
BMI, kg/m2
|
23.8 (3.6)*
|
24.0 (3.6)*
|
0.84
| |
|
Body Lean Mass, kg
|
46.3 (8.8)*
|
49.4 (10.3)*
|
0.35
| |
|
Body Fat Mass, kg
|
18.4 (8.9)*
|
19.4 (10.9)*
|
0.79
| |
|
Fat Mass ratio
|
0.97
|
0.97
|
0.99
| |
|
In men
|
1.05 (0.16)*
|
1.03 (0.14)*
|
0.81
|
≤ 1.5
|
|
In women
|
0.85 (0.10)*
|
0.87 (0.14)*
|
0.74
|
≤ 1.2
|
|
BMD L2-L4 (g/cm2)
|
1.233
|
1.249
|
0.82
| |
|
Cholesterol, g/l
|
1.88 (0.45)*
|
1.61 (0.34)*
|
0.05
|
1.5 – 2.2
|
|
HDL-cholesterol, g/l
|
0.44 (0.08)*
|
0.38 (0.10)*
|
0.10
|
> 0.4
|
|
Triglycerides, g/l
|
1.14 (0.58)*
|
0.99 (0.48)*
|
0.46
|
0.5 – 1.5
|
|
Glucose, g/l
|
0.84 (0.08)*
|
0.83 (0.09)*
|
0.79
|
0.72 - .1.05
|
|
Total alkaline phosphatase, U/l
|
168 (37)*
|
173 (49)*
|
0.73
|
100 – 280
|
|
Bone alkaline phosphatase, μg/l
|
8.1 (3.2)*
|
8.3 (2.6)*
|
0.88
|
5 – 20
|
|
β-Cross-laps, μg/l
|
353 (186)*
|
302 (161)*
|
0.39
|
160 – 440
|
|
25-OH-vitamine D3, μg/l
|
20.7 (8.2)*
|
19.4 (12.0)*
|
0.71
|
22 – 45
|
|
1,25-di-OH-vitaminne D3, ng/l
|
49.1 (18.7)*
|
49.3 (18.4)*
|
0.97
|
25 – 60
|
|
Parathormone, ng/l
|
34.1 (12.9)*
|
35.1 (13.3)*
|
0.83
|
10 - 65
|
|
Cockroft (ml/min)
|
83.9 (21.9)*
|
102.3 (17.3)*
|
0.01
| |
